AbbVie and BMS slash 360 jobs in California, the latest in a streak of biopharma layoffs

Taking a page from the Biogen, Teva and Novartis playbooks, AbbVie and Bristol Myers Squibb are slimming down to the tune of 360 staffers on the West Coast. For BMS, the layoffs are tied to a recent acquisition.